Development of a New Class of Nonimidazole Histamine H3 Receptor Ligands with Combined Inhibitory Histamine N-Methyltransferase Activity-Reference-Cited by-同舟云学术

Development of a New Class of Nonimidazole Histamine H3 Receptor Ligands with Combined Inhibitory Histamine N-Methyltransferase Activity

Published:2002-02-01 Issue:5 Volume:45 Page:1128-1141
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Apelt Joachim¹,Ligneau Xavier¹,Pertz Heinz H.¹,Arrang Jean-Michel¹,Ganellin C. Robin¹,Schwartz Jean-Charles¹,Schunack Walter¹,Stark Holger¹

Affiliation:

1. Institut für Pharmazie, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195 Berlin, Germany, Laboratoire Bioprojet, 30 rue des Francs-Bourgeois, 75003 Paris, France, Unité de Neurobiologie et Pharmacologie Moléculaire (U. 109), Centre Paul Broca de l'INSERM, 2ter rue d'Alésia, 75014 Paris, France, Christopher Ingold Laboratories, Department of Chemistry, University College London, 20 Gordon Street, London WC1H 0AJ, United Kingdom, and Institut für Pharmazeutische Chemie, Biozentrum, Johann...

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0110845

Reference61 articles.

1. Molecular Cloning and Characterization of a New Human Histamine Receptor, HH4R

2. Three loci related to the src oncogene and tyrosine-specific protein kinase activity in Drosophila

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multitargeting nature of muscarinic orthosteric agonists and antagonists;Frontiers in Physiology;2022-09-06

2. Histamine H 3 receptor and cholinesterases as synergistic targets for cognitive decline: strategies to the rational design of multitarget ligands;Chemical Biology & Drug Design;2021-05-15

3. Fragment-like Chloroquinolineamines Activate the Orphan Nuclear Receptor Nurr1 and Elucidate Activation Mechanisms;Journal of Medicinal Chemistry;2021-02-25

4. Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant;ACS Omega;2019-10-02

5. Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds;Journal of Medicinal Chemistry;2018-07-23